Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Return on Equity (2016 - 2025)

iBio (IBIO) has disclosed Return on Equity for 15 consecutive years, with 0.44% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 41.0% to 0.44% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.44%, a 41.0% increase, with the full-year FY2025 number at 1.02%, down 50.0% from a year prior.
  • Return on Equity was 0.44% for Q4 2025 at iBio, up from 0.57% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.25% in Q1 2021 to a low of 2.28% in Q1 2023.
  • A 5-year average of 0.82% and a median of 0.53% in 2025 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: soared 989bps in 2021, then tumbled -200bps in 2023.
  • iBio's Return on Equity stood at 0.27% in 2021, then tumbled by -412bps to 1.37% in 2022, then surged by 57bps to 0.58% in 2023, then plummeted by -46bps to 0.85% in 2024, then surged by 48bps to 0.44% in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Return on Equity are 0.44% (Q4 2025), 0.57% (Q3 2025), and 1.4% (Q2 2025).